KIRA MIKLOS: Open Payments
NPI 1467165050 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 18 payments from 6 companies in 2025. Trend: 2023 $507 · 2024 $747 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $102 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Lilly USA, LLC | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: VRAYLAR, AREXVY, MOUNJARO, REXULTI, Kerendia, ZEPBOUND, SHINGRIX.
Industry payments across CO — which companies pay providers there.
